(Q73342824)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Interleukin-10-induced T cell unresponsiveness can be reversed by dendritic cell stimulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

M L Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

F H Wang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P K Lee

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C M Lin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

91-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

Dendritic cell vaccines for cancer immunotherapy

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900301-1

7 January 2021

10.1016/S0165-2478(00)00301-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137131%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference